The Food and Drug Administration (FDA) is warning consumers about the dangers of using ketamine to treat psychiatric disorders. “Ketamine is not FDA approved for the treatment of any psychiatric disorder,” the FDA said on its Tuesday. “FDA is aware that compounded ketamine products have been marketed for a wide variety of psychiatric disorders...however, FDA has not determined that ketamine is safe and effective for such uses.” Ketamine is the short name for Ketamine hydrochloride, which is a Schedule III controlled substance, according to the FDA. The treatment is FDA-approved as an “intravenous or intramuscular injection solution for induction and maintenance of general anesthesia
Hence then, the article about fda warns of dangers in treating psychiatric disorders with ketamine was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA warns of dangers in treating psychiatric disorders with ketamine )